top of page

Notable Research for Treating PTSD


This pilot study evaluated the use of MDMA-assisted psychotherapy for individuals with chronic, treatment-resistant PTSD. The results showed significant reductions in PTSD symptoms, with 83% of participants no longer meeting the criteria for PTSD two months after treatment. The study demonstrated the potential of MDMA as a therapeutic adjunct for PTSD.

Read more

MDMA for PTSD: Phase 3 Trial

This phase 3 clinical trial assessed the efficacy and safety of MDMA-assisted therapy for severe PTSD. Participants received three MDMA-assisted therapy sessions and showed significant reductions in PTSD symptoms compared to the placebo group. The study confirmed the benefits of MDMA-assisted therapy for PTSD, with 67% of participants no longer meeting PTSD diagnostic criteria.

Read more

Ayahuasca for PTSD

This review explored the potential of ayahuasca as a treatment for PTSD, highlighting anecdotal reports and preliminary studies. The review suggested that the unique psychoactive properties of ayahuasca, combined with the supportive ceremonial context, could provide significant therapeutic benefits for individuals with PTSD.

Read more

bottom of page